Following a conduct review, DLA Piper has opted to stand by Nick West, whose sexist email exchanges with Premier League chief executive Richard Scudamore were leaked last week, after the partner today (21 May) publically apologised for letting down the firm and its clients.
In a verdict that gives the Ministry of Justice at least a temporary reprieve in its legal aid battle with the Bar, the Court of Appeal today (21 May) reversed the Crown Court’s ruling that the ‘OpCotton’ serious fraud trial should be stayed after the defendants failed to find any barrister prepared to represent them on reduced legal aid rates.
Partners who expose malpractice in their own law firm will now be protected by whistleblower legislation, the Supreme Court ruled today (21 May), in a precedent-setting judgment that follows a claim brought by former Clyde & Co partner Krista Bates van Winkelhof.
The practice of law has flipped from vocation to business. Law firms and individual lawyers are measured explicitly in predominantly economic terms.
Allen & Overy (A&O), Hogan Lovells and Skadden, Arps, Slate, Meagher & Flom are among firms to be awarded mandates on British aerospace and defence supplier Cobham’s all-cash acquisition of US communications equipment maker Aeroflex for $1.46bn.
One of the best-known names in the leverage buyout market, Stephen Lucas is set to join Kirkland & Ellis from Weil Gotshal & Manges, where he heads the Wall Street firm’s City banking practice.
Undoubtedly some of the most anticipated financial results of the 2013-14 financial reporting season, Berwin Leighton Paisner (BLP) has unveiled its latest figures, with the top 20 firm’s revenue and profit per equity partner (PEP) up by 6% and 35% respectively, to £246m and £542,000.
Freshfields Bruckhaus Deringer has led on the latest major European mandate for Blackstone, advising the New York Stock Exchange-listed private equity group on its acquisition of a €1.8bn portfolio of cross-border loans and swaps from the National Asset Management Agency (NAMA) in Ireland.
In front of the Commons Business committee last week, Ian Read, chairman and chief executive of Pfizer, made two points in relation to Pfizer’s commitments, assuming it were to succeed in acquiring the Anglo-Swedish drug manufacturer AstraZeneca.
The latest City firm to announce its 2014 partner promotion round, Travers Smith today (19 May) revealed that it has made up two associates to partner, the lowest number in three years.
